Omalizumab is a monoclonal antibody used for the management of:
**Core Concept**
Omalizumab is a recombinant humanized monoclonal antibody that targets the high-affinity IgE receptor (FcεRI) on mast cells and basophils. It is used to modulate the allergic response by reducing the concentration of free IgE in the blood.
**Why the Correct Answer is Right**
Omalizumab works by binding to IgE molecules, thereby preventing them from binding to the FcεRI receptor on mast cells and basophils. This results in a decrease in the release of histamine and other mediators, leading to reduced symptoms of allergic reactions. Omalizumab is particularly useful in the management of severe asthma and chronic spontaneous urticaria, conditions characterized by elevated IgE levels.
**Why Each Wrong Option is Incorrect**
**Option A:** Omalizumab is not primarily used for the management of autoimmune disorders like rheumatoid arthritis. While it does modulate the immune response, its mechanism is more specific to IgE-mediated reactions.
**Option B:** Cetirizine is an antihistamine used to treat allergic reactions, but it does not target IgE directly like omalizumab. Instead, it blocks histamine receptors.
**Option C:** Mepolizumab is another monoclonal antibody, but it targets IL-5, which is involved in eosinophil-mediated inflammation, not IgE.
**Clinical Pearl / High-Yield Fact**
Omalizumab is a high-efficacy treatment for severe asthma, particularly in patients with high IgE levels and a history of multiple exacerbations.
**Correct Answer:** C. Chronic spontaneous urticaria.